wellness
Weekly Horoscope Cancer, October 19-25, 2025: Career success on the horizon
This strange phenomenon could unlock the secrets of the mind
Latin America Sees Sharp Drop in Fertility Rates
ENHERTU® Followed by THP Before Surgery Resulted in a Pathologic Complete Response in 67% of Patients with High-Risk HER2 Positive Early-Stage Breast Cancer in DESTINY-Breast11 Phase 3 Trial
ENHERTU® Reduced the Risk of Disease Recurrence or Death by 53% Versus T-DM1 in Patients with High-Risk HER2 Positive Early Breast Cancer Following Neoadjuvant Therapy in DESTINY-Breast05 Phase 3 Tria
EXPLAINER: Understanding cardiac arrest -- what killed Raila
CrossFit community coming together for Co Down girl with 'super rare' condition: 'She wasn't even supposed to make it past 25 weeks in the womb'
Indian Army soldier saves 8-month old through CPR onboard Rajdhani Express
AdvanCell's 212Pb-ADVC001 demonstrates encouraging safety and compelling anti-tumor activity in Phase 1b in prostate cancer
Nomn champions inclusive healthcare, sign language - Nation Online
By Wycliffe Njiragoma